Literature DB >> 24534548

New treatments for fecal incontinence: update for the gastroenterologist.

Arnold Wald1.   

Abstract

Fecal incontinence is one of the most emotionally devastating of all nonfatal conditions. Many patients do not respond satisfactorily to conservative measures, and there is a need for new and effective strategies when medical therapy fails. The development of sacral nerve stimulation and other forms of neuromodulation and the injection of biologically compatible substances into the anal sphincter complex have brought renewed enthusiasm for using these novel treatments in this underserved population. Because injectable bulking agents such as dextranomer in stabilized hyaluronic acid can be administered in an outpatient setting, this procedure is being marketed to both gastroenterologists and surgeons. This article reviews both sacral nerve stimulation and dextranomer bulking agents and compares their strengths and potential limitations in patients with fecal incontinence.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Injectable Anal Bulking Agents; Neuromodulation; Sacral Nerve Stimulation

Mesh:

Substances:

Year:  2014        PMID: 24534548     DOI: 10.1016/j.cgh.2014.02.013

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  10 in total

1.  Update on the Management of Fecal Incontinence for the Gastroenterologist.

Authors:  Arnold Wald
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-03

2.  Barriers to seeking care for accidental bowel leakage: a qualitative study.

Authors:  Heidi Wendell Brown; Rebecca G Rogers; Meg E Wise
Journal:  Int Urogynecol J       Date:  2016-11-14       Impact factor: 2.894

Review 3.  Fecal incontinence - Challenges and solutions.

Authors:  Nallely Saldana Ruiz; Andreas M Kaiser
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

4.  Relationship Among Anal Sphincter Injury, Patulous Anal Canal, and Anal Pressures in Patients With Anorectal Disorders.

Authors:  David Prichard; Doris M Harvey; Joel G Fletcher; Alan R Zinsmeister; Adil E Bharucha
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-11       Impact factor: 11.382

Review 5.  Pregnancy and postpartum bowel changes: constipation and fecal incontinence.

Authors:  Grace Hewon Shin; Erin Lucinda Toto; Ron Schey
Journal:  Am J Gastroenterol       Date:  2015-03-24       Impact factor: 10.864

6.  Gastric Electrical Stimulation and Sacral Electrical Stimulation: A Long-Term Follow-Up Study of Dual-Device Treatment.

Authors:  Anubhav Agrawal; Sean Lamar Francis; Nicolette Elizabeth Deveneau; Shaily Jain; Christopher Abrasley; Jason Trippe McNeese; Shivangi T Kothari; Christopher J Lahr; Thomas L Abell
Journal:  Dig Dis Sci       Date:  2015-08-18       Impact factor: 3.199

7.  Functional Anorectal Disorders.

Authors:  Satish Sc Rao; Adil E Bharucha; Giuseppe Chiarioni; Richelle Felt-Bersma; Charles Knowles; Allison Malcolm; Arnold Wald
Journal:  Gastroenterology       Date:  2016-03-25       Impact factor: 22.682

Review 8.  Diagnosis and Management of Fecal Incontinence.

Authors:  Arnold Wald
Journal:  Curr Gastroenterol Rep       Date:  2018-03-26

9.  Small-Group, Community-Member Intervention for Urinary and Bowel Incontinence: A Randomized Controlled Trial.

Authors:  Heidi W Brown; Emilie J Braun; Meg E Wise; Shannon Myers; Zhanhai Li; Emmanuel Sampene; Sierra M Jansen; D Paul Moberg; Jane E Mahoney; Rebecca G Rogers
Journal:  Obstet Gynecol       Date:  2019-09       Impact factor: 7.623

10.  Comparative effectiveness of biofeedback and injectable bulking agents for treatment of fecal incontinence: Design and methods.

Authors:  Adil E Bharucha; Marie G Gantz; Satish S Rao; Ann C Lowry; Heidi Chua; Tennekoon Karunaratne; Jennifer Wu; Frank A Hamilton; William E Whitehead
Journal:  Contemp Clin Trials       Date:  2021-06-15       Impact factor: 2.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.